NEOGENOMICS INC|4Jul 7, 7:02 PM ET

CARDOZA GEORGE 4

4 · NEOGENOMICS INC · Filed Jul 7, 2021

Form 4

Period: 2021-07-05

Chief Financial Officer

Transactions

Award
Stock Option (Right to Buy)
2021-07-05$43.95/sh+40,502$1,780,063→ 40,502 total
Exercise: $43.95Exp: 2028-07-05→ Common Stock (40,502 underlying)
Award
Common Stock
2021-07-05+7,584→ 184,356 total

Holdings

Stock Option (Right to Buy)
Exercise: $53.17Exp: 2028-03-02→ Common Stock (35,171 underlying)
35,171
Common Stock
(indirect: By Trust)
20,000
Stock Option (Right to Buy)
Exercise: $8.03Exp: 2023-02-26→ Common Stock (192,500 underlying)
192,500
Stock Option (Right to Buy)
Exercise: $28.33Exp: 2027-03-02→ Common Stock (48,768 underlying)
48,768
Stock Option (Right to Buy)
Exercise: $7.52Exp: 2022-04-28→ Common Stock (50,000 underlying)
50,000
Stock Option (Right to Buy)
Exercise: $19.60Exp: 2024-03-01→ Common Stock (51,459 underlying)
51,459

Footnotes (6)

[F1]On April 28, 2017, Mr. Cardoza was granted 200,000 stock options. These options vested ratably over the first three anniversary dates of the grant date.
[F2]On February 26, 2018, Mr. Cardoza was granted 192,500 stock options. These options vested ratably over the first three anniversary dates of the grant date.
[F3]On March 1, 2019, Mr. Cardoza was granted 51,459 stock options. These options vest ratably over the first four anniversary dates of the grant date.
[F4]On March 2, 2020, Mr. Cardoza was granted 48,768 stock options. These options vest ratably over the first four anniversary dates of the grant date.
[F5]On March 2, 2021, Mr. Cardoza was granted 35,171 stock options. These options vest ratably over the first four anniversary dates of the grant date.
[F6]On July 5, 2021, Mr. Cardoza was granted 40,502 stock options. These options vest ratably over the first four anniversary dates of the grant date.

Documents

1 file